Deals
Perrigo to Buy Omega Pharma of Belgium for $4.5 Billion
This article is for subscribers only.
Perrigo Co. agreed to buy Belgian health-products provider Omega Pharma NV for 3.6 billion euros ($4.5 billion), including debt, in a deal that will expand its presence in Europe.
The acquisition will place Perrigo among the world’s five largest providers of over-the-counter health-care remedies, the company said today in a statement. One-quarter of the purchase will be funded with stock, and the rest will be paid for using cash and debt, it said. The price includes the assumption of 1.1 billion euros of debt.